Conviction: Medium Status: Hold — war thesis monitored; Q4 EPS miss adds caution

---

Editorial Note

NTR at $75.47 is holding up remarkably well despite a Q4 EPS miss and the war premium slowly fading. The strong-up trend signal, golden cross, and +21.3% above SMA200 make this the strongest long-term technical setup in the entire focus list. But RSI 51.8 and +1.9% weekly gain mask the real dynamic: NTR is grinding sideways while waiting for the next binary catalyst — either Hormuz re-escalation (bullish) or ceasefire (bearish). The Q4 EPS miss ($0.83 vs $0.87 consensus) is a yellow flag but revenue grew 5.1% YoY. The 5% buyback approval from TSX provides a share price floor. The split thesis remains: war continuation = $95-100 target, ceasefire = $65-70 floor. At $75.47, you're paying $10 above the floor for the geopolitical optionality. That's cheap if the war continues; that's expensive if it ends.

---

The Story Right Now

Nutrien closed at $75.47 on April 2, up +1.9% on the week, recovering from the ex-dividend dip on March 31. RSI at 51.8 is neutral. The stock has been range-bound between $73 and $77 for two weeks — a consolidation pattern that typically resolves in the direction of the prevailing trend, which for NTR is "strong-up."

The Q4 EPS miss is the new development since the last deep dive. MarketBeat reported Nutrien posted $0.83 EPS vs $0.87 consensus, a modest miss. Revenue rose 5.1% YoY, driven by higher fertilizer prices — the demand side is intact, the execution was slightly soft. The market reaction was muted, suggesting the miss was already priced into the recent pullback from $85.36 highs.

Two constructive catalysts offset the EPS miss. First, Jefferies upgraded NTR to Buy with a $96 target, citing strong potash and nitrogen margins in the favorable geopolitical backdrop. Second, the TSX approved a 5% share buyback program — meaningful for a $36B market cap company, providing mechanical support on any pullback.

The fertilizer price dynamics remain the core thesis. Higher fertilizer prices from the Iran conflict continue to boost NTR's outlook (Investing.com). Urea moved from $450 to $700/mt during the Hormuz closure period. If the spring planting season (Q2) plays out with elevated prices, Q1 earnings (due ~May) will show the full impact — and that's when the analyst targets of $96 (Jefferies) and $100 (Wells Fargo) get tested against reality.

The split thesis has sharpened:

War continues (Hormuz closed through Q2): Spring planting at $700/mt urea = massive earnings beat vs pre-war estimates. NTR's vertical integration (production + 2,000+ retail locations) captures double margin. Target: $95-100.

Ceasefire / Hormuz reopens: Fertilizer prices normalize to $450-500/mt. The premium from $65 (pre-war) to $85 (peak) partly unwinds. But NTR's $6.05B FY2025 EBITDA was achieved BEFORE Hormuz — the baseline floor is $65-70. The potash moat (Saskatchewan Basin, world's lowest cost) and Russia/Belarus sanctions are permanent structural advantages regardless of Iran.

The technical picture is the best in the focus list for long-term trend. NTR is the only focus name with a "strong-up" trend signal, golden cross confirmed, +21.3% above SMA200 ($62.21), and +3.3% above SMA50 ($73.07). The 3M return of +22.4% is second only to ARM (+28.4%). This is a name that's working on both a structural and cyclical basis.

---

Quick Snapshot

---

Action Matrix

---

Price Data

Key Technical Levels

SMA Position

---

Company Overview

One-Liner

Nutrien is the world's largest fertilizer producer (potash, nitrogen, phosphate) and the largest agricultural retailer in North America and Australia — the only way to own both the commodity cycle and the distribution margin in one stock.

Business Model

Key Segments

---

Competitive Analysis

Competitive Moat

Moat Width: Wide Moat Trend: Stable (geopolitical disruption widening vs Western producers; long-term potash supply cycles are real)

---

Management Assessment

Capital allocation: Good — divested Profertil ($600M) to focus on core. Buyback program approved (5% of shares). Consistent $0.55/quarter dividend.

---

Financials

Key Metrics

Quality Checks

---

Valuation

Compelling even without the Hormuz thesis. The forward estimates haven't fully incorporated the nitrogen price spike — Q1 earnings should close that gap.

---

Bull Case

1. Strong-up trend + golden cross + +21.3% above SMA200 — Best long-term technical setup in the focus list
2. Hormuz stays closed through Q2 spring planting — price spike fully realized — Urea $700/mt = massive Q1 earnings beat
3. Jefferies $96 target, Wells Fargo $100 — Analyst upgrades not yet fully reflected
4. 5% share buyback approved by TSX — Mechanical share price support
5. Vertically integrated = double margin capture — 2,000+ retail locations
6. $6.05B FY25 EBITDA achieved BEFORE Hormuz — Floor is real at $65-70
7. 1Y alpha of +32.4% vs SPY — Structural outperformer
8. 3M return +22.4% — Second-best momentum in focus list

---

Bear Case

1. Ceasefire / Hormuz reopens — war premium unwinds — $8-12/share premium at risk
2. Q4 EPS miss ($0.83 vs $0.87) — Execution slightly soft; raises questions about capturing the full price spike
3. -1.2% below SMA20 — Short-term weakness within the strong-up trend
4. Demand destruction from sustained high prices — If urea stays $700/mt, some farmers reduce application
5. Potash capacity glut risk in 2027-28 — NTR + peers all ramping Canadian production
6. RSI 51.8 is neutral — No urgency in either direction; can drift

---

Recent News

---

Related Markets & ETFs

---

Cross-References

---

Related Tickers

---

Catalysts & Timing

---

Dividend Tracker

---

Entry Strategy

Position Sizing

My conviction: Medium — thesis bifurcated by war outcome; strong floor but limited upside catalysts unless Hormuz escalates Target allocation: 2-3%

Entry Approach

---

Research Log

---

The Gold

Key Discoveries

Open Questions

• What's the current urea spot price? Single most important variable for Q1 earnings
• Any ceasefire talks emerging from Iran? Monitor geopolitical feeds
• How does the Q4 EPS miss affect street estimates for Q1?
• Will the buyback program execute quickly enough to matter?
• Q1 earnings date — confirm and calendar

Updated 2026-04-03. Previous version archived as the March 31 note.

Sources

• Fundamentals figures: company-reported results (quarterly/annual filings) as available at the artifact date; predates the desk's EDGAR reconciliation gate — figures not re-verified after publication.